A grantee of the Gates Foundation, Hong Kong-based Phase Scientific built a business on the back of Covid-19 tests. Up next: ...

Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company” or "Zhengye”), a veterinary vaccine manufacturer that ...

In our weekly column, Quick Bites, we round up the latest developments in the alt-protein and sustainable food industry.

Chinese biotech company 3SBio's shares surged early Tuesday after its around US$6 billion licensing deal with Pfizer to develop, manufacture and commercialize a promising cancer drug. Shares were up ...

Finance Income, net was $1.0 million for the three months ended March 31, 2025, compared to $0.7 million in the same period ...

Regeneron develops new medicines and it rang up $3.7 billion in sales for its anti-inflammatory drug Dupixent as a treatment for eczema, asthma and chronic obstructive pulmonary disease, in its latest ...

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international collaboration.

Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosisNIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., a Dutch ...

Congress has not been able to reauthorize environmental statutes for years, with some (most) needing significant attention. EPA relies on 1990 Clean Air Act amendments to sort out air pollution issues ...